Literature DB >> 14773

Rapid intubation with fazadinium and suxamethonium.

S Mehta, K Lewin, K Fidler.   

Abstract

Fazadinium at two dose levels (1 mg/kg and 1.5 mg/kg) and suxamethonium at three dose levels (50 mg, 75 mg and 100 mg) were investigated in 106 adult patients to determine the time interval from injection to tracheal intubation. The intubating conditions were graded according to the scheme described by Lund and Stovner. Suxamethonium 100 mg gave the shortest time interval between the end of injection and intubation. There was no significant difference between the intubation time when smaller doses of suxamethonium (50 mg and 75 mg were used and those when AH8165 (1 mg and 1.5 mg/kg) were given. Suxamethonium 100 mg also produced a significantly higher incidence of excellent intubating conditions. The clinical implications of the findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14773     DOI: 10.1007/BF03006240

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  9 in total

1.  DEATHS ASSOCIATED WITH ANAESTHESIA; OBSERVATIONS ON 600 CASES.

Authors:  O P DINNICK
Journal:  Anaesthesia       Date:  1964-10       Impact factor: 6.955

2.  Changes in intragastric pressure following the administration of suxamethonium. Preliminary report.

Authors:  N ANDERSEN
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

3.  Suxamethonium (succinylcholine) chloride and muscle pains.

Authors:  H C CHURCHILL-DAVIDSON
Journal:  Br Med J       Date:  1954-01-09

4.  The effect of suxamethonium on intragastric pressure.

Authors:  R B ROE
Journal:  Anaesthesia       Date:  1962-04       Impact factor: 6.955

5.  An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study.

Authors:  B R Simpson; L Strunin; T M Savege; B Walton; E I Foley; M P Maxwell; L A Ross; D M Harris
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

6.  The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery.

Authors:  G A Harrison
Journal:  Br J Anaesth       Date:  1972-05       Impact factor: 9.166

7.  Dose-Response curves for tubocurarine, alcuronium and pancuronium.

Authors:  I Lund; J Stovner
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1969

8.  Initial clinical experience with AH 8165D, a new rapidly acting nondepolarizing muscle relaxant.

Authors:  M V Arora; R S Clarke; J W Dundee; J Moore
Journal:  Anaesthesia       Date:  1973-03       Impact factor: 6.955

9.  Intubating conditions with AH 8165 and suxamethoniun.

Authors:  H S Young; R S Clarke; J W Dundee
Journal:  Anaesthesia       Date:  1975-01       Impact factor: 6.955

  9 in total
  3 in total

1.  Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

2.  Clinical trial of fazadinium bromide (fazadon).

Authors:  C E Famewo
Journal:  Can Anaesth Soc J       Date:  1981-03

3.  Neuromuscular blockade for rapid tracheal intubation in children: comparison of succinylcholine and pancuronium.

Authors:  M Cunliffe; V M Lucero; M E McLeod; F A Burrows; J Lerman
Journal:  Can Anaesth Soc J       Date:  1986-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.